Do we need prophylactic anticoagulation in ambulatory patients with lung cancer? A review

Vascular Medicine
Evangelos P DimakakosKonstantinos Syrigos

Abstract

Venous thromboembolism is a common complication of malignancy. Lung cancer is considered one of the most thrombogenic cancer types. Primary thromboprophylaxis is not currently recommended for all ambulatory patients with active cancer. In the present narrative review we aim to summarize recent data on the safety and efficacy of primary thromboprophylaxis as well as on venous thromboembolism risk assessment, focusing on ambulatory patients with lung cancer. A potential benefit from prophylactic anticoagulation with low molecular weight heparins in terms of venous thromboembolism risk reduction and increased overall survival in patients with lung cancer, without a significant increase in bleeding risk, has been reported in several studies. Recent studies also reveal promising results of direct oral anticoagulants regarding their efficacy as primary thromboprophylaxis in patients with cancer, including those with lung cancer. However, the use of different study methodologies and the heterogeneity of study populations among the trials limit the extraction of definite results. More randomized, controlled trials, restricted to a well-characterized population of patients with lung cancer, are greatly anticipated. The use of risk asses...Continue Reading

References

May 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ajay K KakkarRobin C N Williamson
Feb 9, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Clara P W KlerkHarry R Büller
Feb 11, 2005·JAMA : the Journal of the American Medical Association·Jeanet W BlomFrits R Rosendaal
Mar 1, 2006·Archives of Internal Medicine·Helen K ChewRichard H White
Jun 15, 2006·Mayo Clinic Proceedings·Kostandinos SiderasCharles L Loprinzi
Nov 1, 2006·Critical Reviews in Oncology/hematology·T M H NiersD J Richel
Apr 23, 2010·British Journal of Cancer·S Noble, J Pasi
Sep 11, 2010·Blood·Cihan AyIngrid Pabinger
Apr 20, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Frederiek F van DoormaalHarry R Buller
Aug 9, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Luis Corrales-Rodriguez, Normand Blais
Oct 20, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M MandalàUNKNOWN ESMO Guidelines Working Group
Jan 26, 2012·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·Sylvia K HaasUNKNOWN TOPIC Investigators
Feb 18, 2012·The New England Journal of Medicine·Giancarlo AgnelliUNKNOWN SAVE-ONCO Investigators
Mar 14, 2012·Journal of Thrombosis and Haemostasis : JTH·M N LevineJ Julian
May 28, 2013·BMJ Quality & Safety·Brandyn D Lau, Elliott R Haut
Dec 3, 2014·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Taxiarchis V KourelisAlfonso J Tafur
Jan 22, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology
Jun 27, 2015·British Journal of Haematology·Henry G WatsonUNKNOWN British Committee for Standards in Haematology
Sep 18, 2015·Multidisciplinary Respiratory Medicine·Carolina VitaleAntonio Molino
Nov 8, 2015·Japanese Journal of Clinical Oncology·Soichiro IkushimaKeisuke Kondo
Nov 11, 2015·Angiology·E SallaK N Syrigos
Dec 25, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fergus MacbethGareth Griffiths
Apr 21, 2017·The Oncologist·Chiara Alessandra CellaSabino De Placido
Nov 7, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L EkUNKNOWN Swedish Lung Cancer Study Group (SLUSG)
Dec 5, 2018·The New England Journal of Medicine·Marc CarrierUNKNOWN AVERT Investigators
Feb 21, 2019·The New England Journal of Medicine·Alok A KhoranaUNKNOWN CASSINI Investigators
Feb 21, 2019·The New England Journal of Medicine·Giancarlo Agnelli
Mar 9, 2019·Thrombosis Research·Maria Cristina VedovatiCecilia Becattini
Jun 30, 2019·TH Open : Companion Journal to Thrombosis and Haemostasis·Pedro Ruiz-ArtachoUNKNOWN RIETE Investigators
Jun 30, 2019·TH Open : Companion Journal to Thrombosis and Haemostasis·Vanessa PachónRamón Lecumberri

❮ Previous
Next ❯

Citations

Jun 17, 2020·Vascular Medicine·Jorie VersmissenJavid Moslehi

❮ Previous
Next ❯

Software Mentioned

COMPASS
PROTECHT
ONKOTEV
AVERT
CASSINI
CONKO
PHACHS
CAT

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Clinical Journal of Oncology Nursing
Loretta Cavaliere
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Charles W Francis
© 2021 Meta ULC. All rights reserved